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Nonsynonymous and synonymous mutations 
Microevolution 
A B S T R A C T   
To understand SARS-CoV-2 microevolution, this study explored the genome-wide frequency, gene-wise distri-
bution, and molecular nature of all point-mutations detected across its 71,703 RNA-genomes deposited in GISAID 
till 21 August 2020. Globally, nsp1/nsp2 and orf7a/orf3a were the most mutation-ridden non-structural and 
structural genes respectively. Phylogeny of 4618 spatiotemporally-representative genomes revealed that entities 
belonging to the early lineages are mostly spread over Asian countries, including India, whereas the recently- 
derived lineages are more globally distributed. Of the total 20,163 instances of polymorphism detected across 
global genomes, 12,594 and 7569 involved transitions and transversions, predominated by cytidine-to-uridine 
and guanosine-to-uridine conversions, respectively. Positive selection of nonsynonymous mutations (dN/dS 
>1) in most of the structural, but not the non-structural, genes indicated that SARS-CoV-2 has already harmo-
nized its replication/transcription machineries with the host metabolism, while it is still redefining virulence/ 
transmissibility strategies at the molecular level. Mechanistic bases and evolutionary/pathogenicity-related 
implications are discussed for the predominant mutation-types.   
1. Introduction 
On 30 Dec 2019, Li Wenliang in Wuhan, China, first recognized and 
communicated about the outbreak of a contagious illness resembling 
severe acute respiratory syndrome (SARS), which subsequently got 
identified as the 2019 novel coronavirus disease (COVID-19; causative 
agent: SARS coronavirus 2, abbreviated as SARS-CoV-2 [1]). Since then 
COVID-19 has spread to hundreds of countries and infected tens of 
millions of people, killing more than a million. The first whole-genome 
sequence of SARS-CoV-2 was deposited in GenBank (NC_045512.2) on 
January 5 [2]. The positive-sense, single-stranded, 29,903 nucleotide 
long RNA genome contained 16 and 9 non-structural and structural 
genes respectively, plus two untranslated segments of 254 and 229 nu-
cleotides at the 5′ and 3′ ends respectively [2]. High gene-arrangement 
similitudes of SARS-CoV-2 with coronaviruses found in bats (Rhinolo-
phus sinicus) [3,4] and Sunda Pangolin (Manis javanica) [5] indicated 
COVID-19 to be a zoonotic disease [6], even though human to human 
transmission of SARS-CoV-2 is now very well established. 
At the same time as the scientific community is racing to develop 
vaccines and therapeutics against COVID-19 [7], the virus on its part is 
busy accumulating mutations across its pan-genome, some of which may 
well help it evade clinical interventions [8–11]. In this microevolu-
tionary context, the present study analyzes 71,703 global whole-genome 
sequences of this novel coronavirus to reconstruct the phylogeny and 
reveal the trends of point-mutation accumulation. Besides identifying 
the genome-wide frequency, gene-wise distribution, and molecular 
characteristics of all point-mutations detected across these genomes, the 
ratio between the rates of nonsynonymous (missense) and synonymous 
mutations (dN/dS) was determined to understand the selection pres-
sures on the different genes. Mechanistic basis and evolutionary impli-
cations have been discussed for the preponderance of some specific 
types of mutations in SARS-CoV-2. 
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2. Methods and algorithms 
2.1. Comparative genomics 
Of the 83,475 SARS-CoV-2 whole-genome sequences available in the 
repository of Global Initiative on Sharing All Influenza Data (GISAID) on 
21 August 2020, 42.22% were from UK, while the rest were from 107 
other countries. All these sequences were downloaded together with 
their metadata, and the dataset was filtered using the Augur tool kit [12] 
to eliminate undesired sequences. 11,723 entries were removed based 
on the minimum 29,000 nucleotide length cut-off that was set with 
reference to the genome size of the Wuhan strain (NC_045512.2); 
another 49 were removed because they originated from non-human 
sources. In this way, 71,703 GISAID entries remained in the final data-
set used for further study. For all downstream analyses, again, the 
29,903 nucleotide long complete whole-genome of the earliest- 
sequenced SARS-CoV-2 strain from Wuhan (NC_045512.2) was used as 
the reference sequence. The software package called MicroGMT or Mi-
crobial Genomics Mutation Tracker [13] was used to identify modifi-
cations in the genome sequences analyzed. This package essentially uses 
Minimap2 [14] and Bcftools [15] to map individual genomes against the 
reference and store the results in a Variant Call Format (VCF) table. It 
further utilizes the SnpEff tool [16] to characterize all the detected 
mutations at the level of the nucleotide as well as the amino acid in the 
translated sequence. Although MicroGMT also reports instances of 
insertion and deletion in the sequences compared, the current study 
focused only on the point-mutation data, which were further verified as 
follows. The software MAFFT [17] was used with default options to align 
all the whole-genome sequences included in the dataset. Polymorphisms 
(base substitutions) were identified in the individual genomes using the 
software SNP-sites [18], which specifically identifies single nucleotide 
polymorphisms (SNPs) from aligned multi-fasta sequence files. Subse-
quently, the VCF file generated from the SNP-site analysis was processed 
using the software VCFtools [19] to enumerate all transition and 
transversion events within the dataset of aligned whole-genome se-
quences. Frequency of point mutations (Mf) in the SARS-CoV-2 pan- 
genome, or a given segment (locus) of the pan-genome, was calculated 
as Pi / (Ln × Ns), where Pi is the number of instances of polymorphism 
detected within the genome/locus, Ln is the nucleotide length of the 
genome/locus, and Ns is the number of sequenced entities present in the 
dataset. dN/dS (also known as ω or Ka/Ks), which is the ratio between 
the rates of nonsynonymous (dN) and synonymous (dS) mutations, was 
determined for all the individual genes of SARS-CoV-2, based on like-
lihood analysis using the software package HyPhy [20]. Sequence sim-
ilarities between SARS-CoV-2 genome pairs were computed using the 
software FastANI, which uses a high throughput method for average 
nucleotide identity analysis [21]. 
2.2. Phylogenomic analyses 
Evolutionary relationship between the existing SARS-CoV-2 lineages 
was inferred from a phylogenetic tree constructed based on a subset of 
the 71,703 whole-genome sequences used for studying mutation accu-
mulation trends. Sub-sampling was necessary because it is not possible 
to meaningfully display 71,703 sequences in a single phylogenetic tree. 
This sub-dataset, comprising 4618 complete whole-genome sequences, 
was created using the software package Augur [12], and by means of 
including (in an unbiased way) 150 genomes per geographical region 
(continent) per month since the first Wuhan strain was sequenced 
(NC_045512). Multiple sequence alignment was also created using the 
Augur tool kit of the Nextstrain package. Further alignment was carried 
out using the software IQ-TREE 2 which uses the maximum likelihood 
method for tree construction [22]; Generalised Time Reversible (GTR) 
model was followed to construct the phylogenetic tree, which was 
finally visualized in the software Auspice (https://auspice.us). For the 
labeling of clades in the phylogenetic tree, type-defining marker 
mutations were downloaded from the Nextstrain github repository 
which comes as a package within the Nextstrain tool (https://github. 
com/nextstrain/ncov). Rules of clade-labeling followed were those 
mentioned in the website located at https://nextstrain.github.io/ncov 
/naming_clades.html. Thus, clades were labeled based on the 
geographical origin of the sequences, plus three different concepts of 
clade nomenclature that are in use for COVID-19, namely (i) the dy-
namic clade nomenclature system PANGOLIN [23] (ii) Year-Letter 
nomenclature system proposed by Hodcroft et al. (https://nextstrain. 
org/blog/2020-06-02-SARSCoV2-clade-naming), and (iii) the system 
proposed by Tang et al. [24], and followed by GISAID, which names 
major clades based on nine distinct marker mutations spread over 95% 
of the known SARS-Cov-2 diversity. 
In order to elucidate the biogeography and microevolution of SARS- 
CoV-2 in India, the latest hotspot of the COVID-19 pandemic, we 
reconstructed the phylogeny using a separate sub-dataset (derived from 
the same 71,703 GISAID sequences) that included a large number of 
sequences from Indian strains, alongside representative sequences from 
all other geographical areas to enable understanding of the whole dy-
namics from a global perspective. This sub-dataset building involved 
‘focal’ sampling for India and ‘selective’ sampling for other geographical 
areas, both following custom rules laid down in Nextstrain: for the 
‘focal’ country (India), up to 300 sequences, or whatever maximum 
number (<300) is available, per month for each year under consider-
ation; for contextual sampling, 50 such whole-genome sequences per 
month per country that are genetically associated to the ‘focal’ samples 
based on the priority call criterion called ‘Proximity’. This approach 
short-listed 5778 whole-genome sequences, of which 1148 belonged to 
the ‘focal’ country India. These 5778 sequences were analyzed using the 
same methodology as the one described above for the global phylogentic 
tree, following which the Indian sequences were mapped as per their 
clade affiliation and indicated using the GISAID and Year-Letter clade 
nomenclature systems. 
3. Results and discussions 
3.1. Small but phylogenetically significant divergences in global SARS- 
CoV-2 genomes 
Average nucleotide identity (ANI, for a Kmer size of 16, over a 
fragment size of 1000 nucleotides) and sequence length coverage for all 
the pairwise alignments possible between the 11,189 complete whole- 
genome sequences available simultaneously in GISAID and NCBI 
SARS-CoV-2 database (https://www.ncbi.nlm.nih.gov/sars-cov-2/) on 
21 August 2020 showed that in all the cases both identity and coverage 
were within 99 and 100% (notably, ANI calculation was not possible for 
all the 71,703 GISAID genomes retrieved on 21 August 2020). Whilst 
individual SARS-CoV-2 genomes differed only by a few nucleotides, the 
small sequence divergences across geographies indicated that within the 
short time span of the current pandemic, the pan-genome has diversi-
fied, and the quasispecies reservoir has expanded, rapidly for this novel 
coronavirus. This holds major implications for the adaptation of the 
virus within human hosts, and in doing so have serious consequences on 
the resultant pathogenesis, disease complications, and control [25]. 
The overall evolutionary paths traced thus far by SARS-CoV-2 was 
delineated by labeling the 4618 global (GISAID) sequences on the 
phylogenetic tree using three different concepts of clade nomenclature 
defined in the web-based resoure https://nextstrain.github.io/ncov/ 
(Figs. 1A-1C). Information regarding the geographical origin of the se-
quences analyzed was also used to label the tree (Fig. 1D). Fig. 1A, where 
the tree topology was labeled according to the dynamic clade nomen-
clature system [23] called Phylogenetic Assignment of Named Global 
Outbreak LINeages (PANGOLIN), reflected the global preponderance of 
the ancestral SARS-CoV-2 lineage identified as Clade A. Notably, this 
ancestral clade [23] is epitomized by the 29,872 nucleotide long genome 
LR757995, which was isolated from Wuhan on 26 December 2019, 
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Fig. 1. Radial trees representing the phylogenetic relationships among the different SARS-COV-2 genomes sequenced till 21 August 2020. (A-D) shows the phylogeny 
reconstructed based on 4618 global sequences extracted from the universal dataset of 71,703 complete whole-genomes. (A) identifies and labels the clades based on 
the dynamic clade nomenclature system PANGOLIN [23]. This convention currently defines 62 evolved lineages based on shared mutations, of which 10 initially- 
described lineages (old Nextstrian Clades) have been shown. (B) identifies and labels the clades based on Year-Letter naming as per the nomenclature system 
proposed by Hodcroft et al. (https://nextstrain.org/blog/2020-06-02-SARSCoV2-clade-naming). (C) identifies and labels the clades based on the nomenclature 
system proposed by Tang et al. (https://academic.oup.com/nsr/article/7/6/1012/5775463) and which is also followed by GISAID. (D) labels the entities analyzed 
based on the geographical region (continent) from the sequences were obtained. (E-F) shows phylogeny based on 1148 Indian and 4630 global sequences extracted 
from the universal dataset of 71,703 complete whole-genomes. (E) shows only the Indian sequences, and identifies and labels the clades based on Year-Letter 
nomenclature system. (F) also shows only the Indian sequences, and identifies and labels the clades based on GISAID nomenclature system. 
C. Roy et al.                                                                                                                                                                                                                                     
Genomics 112 (2020) 5331–5342
5334
sequenced, and submitted to GenBank on 30 January 2020. The 
PANGOLIN nomenclatural approach also illustrated the clear diver-
gence of Clade A from the other SARS-CoV-2 major-clade named B, the 
typical representative (NC_045512.2) of which was also isolated from 
Wuhan on 26 December 2019, but submitted to GenBank on 12 January 
2020. Albeit the genome sequence NC_045512.2 was deposited at an 
earlier date, the clade it represents (B) has apparently diverged at a later 
stage of evolution from Clade A alongside the other A-derived linages 
A1a and A7. 
On the other hand, Fig. 1B, where branches of the phylogenetic tree 
have been labeled according to the Year-Letter nomenclature system (i. 
e. with the year of identification followed by an alphabet) of Hodcroft 
et al., 2020 (https://nextstrain.org/blog/2020-06-02-SARSCoV2-cla 
de-naming), showed that the largest lineage A2 identified by 
PANGOLIN clade-nomenclature system, emerged in the year 2020 and 
evolved further into a number of sub-lineages characterized by muta-
tions in specific nucleotide positions (these have been designated in Fig. 
1B as branches 20A, 20B, 20C, etc.). This system, which names new 
major clades only when the frequency of a clade exceeds 20% in a 
representative global sample and that clade differs in at least two 
nucleotide positions from its parent clade, not only corroborated the 
early (i.e. 2019) advent of the ancestral lineages of the PANGOLIN clade 
A but also identified their derivatives which formed PANGOLIN Clade B. 
Consistent with the above phylogenetic interpretations, labeling of 
the tree with the third clade-nomenclature convention, which was 
proposed by Tang et al. [24] and is also followed by GISAID, indicated 
that the two original lineages, named as S and L (essentially equivalent 
to 19A and 19B of the Year-Letter nomenclature system), has diversified 
and thus far given rise to a total of seven clades, based on nine distinct 
marker mutations spread over 95% of the known SARS-Cov-2 diversity 
(Fig. 1C). As per the data available till 21 August 2020, Clade L is 
apparently more populous than Clade S, and has diversified further into 
V and G, with G splitting further into G, GH and GR (essentially equiv-
alent to the old A2a clade of PANGOLIN, or the 20A, 20C and 20B of 
Year-Letter, nomenclature systems). 
Labeling of the phylogenetic tree on the basis of the geographical 
origin of the sequences showed that members of the original and early- 
diverged clades (S and L, and V, respectively) are still mostly spread over 
Asian countries, whereas the recently derived clades (G, GH and GR) are 
distributed across the globe, especially in Europe and North America 
(Fig. 1D). India being the latest hotspot of the COVID-19 pandemic, 
recording >50,000 cases of infection and > 700 cases of fatality daily 
between July-end and October-middle 2020 (https://www.worldomet 
ers.info/coronavirus/country/india/), the phylogeny and biogeog-
raphy of Indian SARS-CoV-2 isolates was analyzed using the specialized 
(GISAID-derived) dataset encompassing 1148 and 4630 genome se-
quences of Indian and global origins respectively. The phylogenetic tree 
topology obtained with this India-focused dataset (Fig. 1E and F) was 
essentially congruent with that obtained for the global dataset of 4618 
GISAID sequences (Figs. 1A-1D). Mapping of the Indian sequences on 
this tree topology using the GISAID (Fig. 1E) and Year-Letter (Fig. 1F) 
clade nomenclature systems showed that all the mutation-types which 
epitomize the major clades of global SARS-CoV-2 evolution are also 
present in India, albeit at potentially different frequencies of distribution 
within the country’s viral population. For instance, the relatively lower 
number of sequences populating the two emerging lineages 20A/ 
20268G and 20A/15324 T can be clearly seen in Fig. 1F which, in turn, 
corroborated the hypothesis that in the Asian countries the ancestral 
lineages are still more prevalent than the recently-derived mutational 
groups. 
3.2. Gene-wise mapping of the substitution mutations recruited in global 
SARS-CoV-2 genomes 
Multiple alignment of the 71,703 SARS-CoV-2 whole-genome se-
quences investigated in this study (29,903 completely aligned 
nucleotide positions, with reference to the 5′ to 3′ sequence of 
NC_045512.2, the earliest-sequenced genome from Wuhan), revealed 
20,163 instances of single nucleotide substitution (polymorphism) 
across the genomes participating in the alignment (Supplementary File 
1, Table S1). Overall, these point mutations have taken place at a fre-
quency (Mf) of 9.4 × 10− 6, i.e. [20,163 / (29,903 × 71,703)]. On the 
other hand, frequency of point mutations (Mf) in the 21,290 nucleotide 
long genomic locus encoding non-structural proteins or Nsps (Fig. 2) 
was found to be 8.78 × 10− 6, i.e. [13,417 / (21,290 × 71,703)]. Mf for 
the 8112 nucleotide long genomic locus encoding structural proteins 
(Fig. 2) was higher, i.e. 1.07 × 10− 5 = [6199 / (8112 × 71,703)], while 
that for the 493 nucleotide long total untranscribed region (UTR) was 
highest, i.e. 1.54 × 10− 5 = [547 / (493 × 71,703)]. Genes-wise, nsp1 and 
orf7a were the most mutation-prone non-structural and structural gene, 
as their Mf values were 1.12 × 10− 5 = [433 / (541 × 71,703)] and 1.37 
× 10− 5 = [359 / (366 × 71,703)] respectively; Mf was also comparably 
high for nsp2 (1.08 × 10− 5) and orf3a (1.35 × 10− 5). The 20,163 in-
stances of point mutation (polymorphisms / single nucleotide sub-
stitutions) detected across 71,703 SARS-CoV-2 genomes corresponded 
to only 16,002 nucleotide positions of the global alignment. This has 
happened in such a way that 12,203 positions each involved one specific 
substitution in one particular strain; 3437 positions each involved two 
different substitutions in two different strains; and 362 positions each 
involved three different substitutions in three different strains (Supple-
mentary File 1, Table S1). This distribution showed that 53.5% (i.e. 
16,002 / 29,903) of the SARS-CoV-2 pan-genome has developed poly-
morphism via generation of small but definite mutations across the 
plethora of strains disseminated globally since the COVID outbreak in 
December 2019. 
3.3. High rate of missense (nonsynonymous) mutations in the structural 
protein-coding genes 
SARS-CoV-2 has experienced strong selection pressure over a short 
period of time. For animal viruses, in general, forces of selection (fitness 
constraints) emanate from host immunogenic responses, and also during 
replication and transmission between hosts. Evolutionarily fit (selected) 
strains develop tropism, and infect different cell-types or tissues of the 
host, reproduce within them, and in turn give rise to a variety of new 
strains having diverse chronic to acute infectious characteristics 
[26,27]. Genomic data can reveal where, when, and (sometimes) how 
viral pathogens have responded to various forces of natural selection. In 
the context of codon models, natural selection of any genetic locus is 
typically measured using the parameter dN/dS, which represents the 
ratio between the global rates of nonsynonymous (dN) and synonymous 
(dS) mutation accumulation in that locus. Fig. 3 graphically depicts the 
synonymous, missense, or stop-codon-generating nature of all point 
mutations detected in the 71,703 SARS-CoV-2 genomes, while their 
molecular details are all given in Supplementary File 1, Table S1. Based 
on these data a likelihood-based analysis was carried out to determine 
dN/dS values for all the individual genes of SARS-CoV-2. For any genetic 
locus, trends of positive Darwinian selection yield dN/dS >1, whereas 
tendencies of negative selection, or selective removal of alleles that are 
deleterious, result in dN/dS <1 [28]. In our analysis, all the SARS-CoV-2 
genomic loci encoding Nsps, except nsp11, were found to have dN/dS 
values <1; among the structural genes, the same was true for S and M 
(genes for the structural proteins Orf3a, E, Orf6, Orf7a, Orf8, N, and 
Orf10, however, had dN/dS >1; Table 1). These numbers indicated that 
in the Nsp-coding genes of SARS-CoV-2 (except nsp11) missense point 
mutations are under purifying selection; in contrast, for the structural 
protein-coding genes (except S and M), missense point mutations tend to 
result in positive selection, thereby becoming potent drivers of evolution 
of this virus. Interestingly, most of the structural protein-coding genes 
that are under positive selection (i.e. the ones having dN/dS >1) confer 
abilities to infect host cells via evading the immune system (specifically, 
the innate immune system), and eventually induce apoptotic pathways 
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Fig. 2. Gene-wise localization of all the transitions and 
transversions detected in the 71,703 SARS-CoV-2 genomes 
analyzed (the graphics are based on the data given in Sup-
plementary File 1, Table S1). Probability density plots 
(showing the distributions of the mutation-types) are given for 
all the individual genes in their respective lower panels. 
Nucleotide positions (with reference to the 5′ to 3′ sequence of 
NC_045512.2, the earliest-sequenced SARS-CoV-2 genome) 
covered by each gene is plotted in the X axis. Multiple 
mutation-types, when detected at a single nucleotide-position, 
are indicated as multi-color (stacked) vertical bars.   
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[29–35]. Consequently, brisk amino acid changes in these protein se-
quences may well be instrumental in allowing the virus innovate newer 
techniques to fulfil its pathogenic objectives. From a holistic evolu-
tionary perspective based on the above considerations, SARS-CoV-2 
seems to have already succeeded in stably synchronizing its replica-
tion and transcription machineries with the host’s metabolic environ-
ment (as its non-structural genes are clearly recruiting less missense 
mutations). The virus, however, by means of actively recruiting more 
missense mutations in its structural genes, is still testing newer bio-
physical options to increase the efficiency of its molecular contrivances 
for virulence and transmissibility (pathogenicity). 
3.4. High frequency of C➔U and G➔U mutations across global SARS- 
CoV-2 genomes 
Of the 20,163 instances of polymorphism identified across global 
SARS-CoV-2 genomes, 12,594 and 7569 involved transition and trans-
version mutations respectively. In this way, a transition:transversion 
ratio of 1.66 characterized the nucleotide substitution bias of SARS-CoV- 
2. Notably, the prevalence of transition mutations in SARS-CoV-2 is 
higher than what is expected if transition and transversion events took 
place randomly. Individually also, all the SARS-CoV-2 genes had tran-
sition:transversion ratios >1. 
Of the total 12,594 transition mutations encountered, maximum, i.e. 
Fig. 3. Gene-wise representation of the synonymous, 
missense, or stop-codon-generating nature of all point 
mutations detected in the 71,703 SARS-CoV-2 genomes 
analyzed (graphics based on the data given in Supple-
mentary File 1, Table S1). Probability density plots 
(showing the distributions of the mutation-types) are 
given for all the individual genes in their respective 
lower panels. Nucleotide positions (with reference to 
the 5′ to 3′ sequence of NC_045512.2, the earliest- 
sequenced SARS-CoV-2 genome) covered by each gene 
is plotted in the X axis. Multiple mutation-types, when 
detected at a single nucleotide-position, are indicated as 
multi-color (stacked) vertical bars.   




Locus-wise distribution of the total 20,163 instances of polymorphism detected in the SARS-CoV-2 pan-genome based on 71,703 complete whole-genomes sequenced globally until 21 August 2020.  
Locus (length 
in bp) 
Number of transitions detected 
(Ts) 




No. of missense 
mutations 
No. of synonymous 
mutations 
dN/dS 
A➔G G➔A C➔U U➔C A➔U U➔A C➔A A➔C C➔G G➔C G➔U U➔G 
5’ UTR (265) 31 33 47 35 146 21 17 15 11 8 10 30 10 122 268 1.41 × 10− 5 NA NA NA 
nsp1 (541) 57 79 81 68 285 20 25 14 7 4 9 54 15 148 433 1.12 × 10− 5 271 155 0.7398 
nsp2 (1914) 253 219 294 215 981 52 67 75 82 7 12 156 52 503 1484 1.08 × 10− 5 996 477 0.9479 
nsp3 (5836) 707 477 718 632 2534 154 169 175 200 34 53 388 124 1297 3831 9.15 × 10− 6 2448 1351 0.5803 
nsp4 (1500) 146 107 191 178 622 36 45 40 19 4 16 69 37 266 888 8.25 × 10− 6 521 360 0.5126 
nsp5 (918) 86 52 112 97 347 16 24 21 23 1 6 50 17 158 505 7.67 × 10− 6 310 190 0.6417 
nsp6 (870) 83 67 103 104 357 23 28 24 13 7 15 65 24 199 556 8.91 × 10− 6 337 210 0.7000 
nsp7 (249) 29 16 35 23 103 4 8 8 7 3 2 14 8 54 157 8.79 × 10− 6 86 70 0.4999 
nsp8 (594) 58 45 71 59 233 12 12 8 15 2 4 33 8 94 327 7.67 × 10− 6 187 132 0.4892 
nsp9 (339) 34 30 48 26 138 5 7 13 5 0 2 17 10 59 197 8.10 × 10− 6 108 88 0.4933 
nsp10 (417) 31 19 51 45 146 8 7 12 8 3 5 18 8 69 215 7.19 × 10− 6 119 94 0.4187 
nsp11 (39) 2 4 5 3 14 1 2 0 1 2 1 3 0 10 24 8.58 × 10− 6 19 5 1.132 
nsp12 (2847) 259 175 319 285 1038 55 65 54 53 13 20 219 44 523 1561 7.64 × 10− 6 906 637 0.6057 
nsp13 (1713) 181 96 200 173 650 37 39 53 33 6 12 133 29 342 992 8.08 × 10− 6 583 405 0.4500 
nsp14 (1581) 140 107 198 172 617 24 38 32 49 10 15 133 33 334 951 8.39 × 10− 6 568 373 0.4024 
nsp15 (1038) 149 96 112 110 467 38 30 32 39 4 21 94 21 279 746 1.00 × 10− 5 514 228 0.3937 
nsp16 (894) 88 68 90 106 352 29 19 23 20 7 7 70 23 198 550 8.58 × 10− 6 342 200 0.4554 
geneS (3822) 346 246 428 417 1437 173 107 141 117 47 122 309 103 1119 2556 9.32 × 10− 6 1615 906 0.6193 
orf3a (828) 89 86 137 114 426 42 38 55 40 15 36 117 35 378 804 1.35 × 10− 5 588 195 1.5013 
gap 2 1 2 1 6 1 0 0 1 0 0 0 0 2 8 ND NA NA NA 
geneE (228) 15 19 30 32 96 8 10 12 6 8 6 24 6 80 176 1.08 × 10− 5 110 63 1.0206 
gap 4 1 4 9 18 3 1 0 0 2 1 5 1 13 31 ND NA NA NA 
geneM (669) 50 40 82 60 232 22 14 21 11 7 17 55 18 165 397 8.28 × 10− 6 209 183 0.6548 
gap 1 1 0 0 2 1 1 0 1 0 0 0 0 3 5 ND NA NA NA 
orf6 (186) 22 11 19 35 87 15 7 8 4 1 5 19 5 64 151 1.13 × 10− 5 99 46 1.3944 
gap 2 0 1 0 3 0 0 0 1 0 1 0 0 2 5 ND NA NA NA 
orf7a (366) 44 30 65 54 193 23 22 20 17 12 13 47 12 166 359 1.37 × 10− 5 241 95 1.1946 
gap 15 11 22 25 73 6 10 1 4 0 6 15 6 48 121 ND NA NA NA 
orf8 (366) 40 32 46 63 181 22 14 22 10 8 19 51 13 159 340 1.30 × 10− 5 228 92 1.4522 
gap 2 0 1 0 3 0 0 1 1 0 1 1 0 4 7 ND NA NA NA 
geneN (1260) 160 142 215 102 619 92 33 65 52 30 58 169 24 523 1142 1.26 × 10− 5 763 366 1.2633 
gap 1 3 6 0 10 1 0 4 0 0 1 4 0 10 20 ND NA NA NA 
orf10 (117) 10 8 16 14 48 6 3 1 3 2 3 9 2 29 77 9.18 × 10− 6 53 19 1.2981 
3’ UTR (229) 37 29 34 30 130 19 15 17 12 9 21 43 13 149 279 1.70 × 10− 5 NA NA NA 
Pan-genome 
(29903) 
3174 2350 3783 3287 12,594 969 877 967 865 256 520 2414 701 7569 20,163 9.4 × 10− 6 12,221 6940 NA 
ND = not determined. 
NA = not applicable. 
dN = rate of missense (non-synonymous) mutation accumulation (ratio between the number of non-synonymous mutations and non-synonymous sites). 
dS = rate of synonymous mutation accumulation (ratio between the number of synonymous mutations and synonymous sites). 
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3783, featured C➔U conversion, which was 30% of the total transition 
count (Table 1). Individually, again, most of the SARS-CoV-2 genes were 
found to have C➔U conversion as the predominant transition-type 
across the global genomes analyzed; only in nsp16, geneE, orf6 and 
orf8 was U➔C most prevalent (Table1). Of the 7569 transversions 
detected across global SARS-CoV-2 genomes, an overwhelming 2414 
(31.9%) featured G➔U conversion (Table 1). Individually, all the SARS- 
CoV-2 genes had G➔U conversion as the most predominant trans-
versions-type. 
3.5. Significance of copious mutations in non-structural genes 1 and 2, 
and most structural genes, especially orf3a and orf7a 
Since RNA viruses encode their own genome replication machineries 
(and do not depend on the hosts’ replication systems as the DNA viruses 
do), they can optimize their mutation rates to achieve evolutionary 
fitness. This leads to an unrelenting generation of genomic variants for 
any RNA virus, alongside a rivalry among the extant variants, including 
the more advanced ones that are added to the viro-diversity over time 
[36]. Consequently, all active genomic variants maintained within 
global/local RNA virus populations (quasispecies) come to possess equal 
abilities to replicate and complete the infection cycle [36]. In this 
context, the divergence of several lineages and sub-lineages of SARS- 
CoV-2 since the December-2019 outbreak (via generation of small mu-
tations across its world-wide strains) - alongside the more or less effi-
cient circulation of its two original major-lineages (clades indicated as S 
and L in Fig. 1) across distinct geographies - reflects the equivalent 
pathological and evolutionary fitness of all its extant quasispecies. This 
rich stock of genotypic, and therefore potentially phenotypic, variants is 
likely to hold major implications for potential multifaceted adaptations 
of this novel coronavirus within human hosts, and in doing so have 
serious consequences on the resultant pathogenesis, disease complica-
tions and control [25]. 
Viruses that have evolved to survive via changing their hosts are 
extremely skilled molecular manipulators; the key to their ecological 
fitness is attributed to their ability to subvert host defense systems to 
ensure survival, replication and proliferation [37]. Coronavirus- 
encoded accessory proteins, in general, play critical roles in virus-host 
interactions and modulation of host-immune responses, thereby 
contributing to their pathogenicity [38,39]. nsp1 and nsp2 are the most 
mutation-prone non-structural genes of SARS-CoV-2, as they have the 
highest Mf values among all such genes (Table 1). Nsp1 is known to 
inhibit translation by binding to the host’s 40S ribosome, and also 
inhibit IFN signaling, while Nsp2 inhibits the two host proteins proin-
hibitin1 and proinhibitin2 to disrupt the cellular environment [33]. 
Copious mutations in these two genes, therefore, can help the virus 
innovate novel molecular routes to evade host immunogenic response. 
With regard to the 16 non-structural genes of SARS-CoV-2 it is 
remarkable that only nsp11 has a dN/dS value >1 (Table 1). The exact 
function of Nsp11 is not known. However, in Arterivirus, this protein has 
been characterized as a Nidoviral uridylate-specific endoribonuclease 
(NendoU) that is associated with RNA processing [29]. So, a dN/dS vaue 
>1 for nsp11 could be indicative of an intrinsic versatility of this gene in 
contriving newer ways of shielding the genetic material from the host’s 
innate-immune system. 
There is a clearcut distinction in the cell-death related consequences 
of different viral infections. While Herpesviruses, Poxviruses, Adenovi-
ruses, and Baculoviruses bring about reduction of cell death, SARS-CoV, 
Ebola, Poliovirus, West Nile virus and Hepatitis B virus are capable of 
increasing cell death [40]. Earlier studies had reported that the acces-
sory protein Orf3a of SARS-CoVs has pro-apoptotic activity [41]; very 
recent studies further implicated this protein of SARS-CoV-2 in inducing 
extrinsic apoptotic pathway through a unique membrane-anchoring 
strategy [34]. In view of these key roles of Orf3a in SARS-CoV-2 path-
ogenicity, and thereby transmissibility, the global existence of 804 in-
stances of point mutations (426 transitions with 137 C➔U substitutions 
and 378 transversions with 117 G➔U substitutions) in the orf3a locus 
(Table 1; Supplementary File 1, Table S1; Figure2; Supplementary File 2, 
Fig. S1), including several nonsynonymous ones (Fig. 3), appears to be a 
part the insidious strategies of the virus towards completion of its life 
cycle and killing of host cells. The intrinsic molecular plasticity of orf3a 
activity is underscored by the fact that these copious mutations have not 
hampered the pathogenic aptitude of the virus. Furthermore, in this 
context it is noteworthy that orf3a is not only one of the most mutation- 
prone structural genes (Mf second highest among all such genes), its dN/ 
dS value is also >1 (Table 1). 
Furthermore, in the context of the structural genes of SARS-CoV-2 it 
is noteworthy that orf7a is the most mutation-prone (Mf = 1.37 × 10− 5), 
and also has a dN/dS value of 1.2 (Table 1). Globally, the gene en-
compasses 359 instances of point mutations, of which 193 are transi-
tions with 65C➔U substitutions, and 166 are transversions with 47 G➔U 
substitutions (Table 1; Supplementary File 1, Table S1; Figure2; Sup-
plementary File 2, Fig. S1). In all SARS-CoVs, the type I membrane 
protein encoded by this gene is known to interact with bone marrow 
stromal antigen-2 (BST-2) and may play a role in viral assembly or 
budding events unique to SARS-CoVs [33]. Budding events are central to 
the transmissibility of SARS-CoV-2, so recruitment of copious mutations, 
especially nonsynonymous ones, in this structural gene (Fig. 3) affords 
novel molecular options to increase the efficiency of virulence (patho-
genicity) of the virus. 
3.6. Physicochemical underpinnings of the preponderance of C➔U and 
G➔U substitutions 
In view of the overwhelming preponderance of C➔U and G➔U 
transitions in the global mutation spectrum of SARS-CoV-2 (as compared 
to all other transition and transversion mutations respectively) it seems 
likely that in the ecological context of this novel coronavirus some 
physicochemical and/or biochemical mutagen is more instrumental in 
bringing about this selective change, over and above the general repli-
cation error-induced mechanism of mutagenesis. Cytosine can convert 
to uracil through processes akin to hydrolytic deamination under the 
action of ultra-violet (UV) irradiation, which is well established in the 
context of DNA [42]. C➔U conversion is also possible chemically under 
the mediation of bisulfite reagents [43] that are frequently used as 
disinfectants, antioxidants and preservative agents. Incidentally, several 
control techniques involving heating, sterilization, ultraviolet germi-
cidal irradiation (UVGI) [44] and/or chemical disinfectants [45] are 
being used currently to reduce the risk of viral infection from contam-
inated surfaces. Of these, intense UV-C irradiation is at the forefront of 
our fight against COVID-19, so indiscriminate use of the same may well 
accelerate the incidence of C➔U mutations in global SARS-CoV-2 ge-
nomes. Furthermore, UV’s specificity for targeting two adjacent py-
rimidine nucleotides is long known [46], while in the context of DNA, 
UV-induced signature mutations collated from existing data on cells 
exposed to UVC, UVB, UVA or solar simulator light, have been 
confirmed as C➔T in ≥60% dipyrimidine sites, of which again ≥5% is 
CC➔TT [47]. In consideration of the above facts, it seems likely that UV 
irradiation is the potential cause of not only the global preponderance of 
C➔U point mutations across SARS-CoV-2 genomes, but also the low 
abundance of two consecutive cytidines in all lineages of this novel 
coronavirus. For instance, the 29,903 nucleotide RNA genome 
(NC_045512.2) of the SARS-CoV-2 reference strain from Wuhan (China) 
has 22.28% of its genome in the form of two consecutive pyrimidine 
nucleotides (YY), with the most predominant being UU (8.15%) fol-
lowed by CU (6.85%), UC (4.70%), and lastly CC (2.57%). 
Errors resulting from replication as well as translation may be 
instrumental in rendering the G➔U mutations prevalent across global 
SARS-CoV-2 genomes. RNA viruses mutate vastly as a result of their 
RNA-dependent RNA polymerases (RdRPs) being error prone. From the 
host’s view point, a propensity for incorrect protein synthesis is ushered 
when cells are stressed due to viral infection, and under such 
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circumstances the viral RNA itself becomes prone to mistranslation [48]. 
It is therefore conceivable that SARS-CoV-2, in addition to classical 
mutations acquired from error-prone replication at the genomic level, 
uses the mistranslated replication-cum-transcription complex for the 
development of diverged genomic lineages [49,50]. In other words, 
when the viral infection discharges its positively-sensed RNA-genome 
into the host cell, errors in the RdRP crops up via mistranslation [51,52]; 
the consequent blend of wild-type and changed RdRP enzymes through 
its replication activities give rise to a range of viral genome-variants or 
quasispecies, even within a single transmission event [50]. Those vari-
ants which have the best viral fitness, eventually, endure and become 
predominant in the population. In this context, it is further noteworthy 
that both tautomeric and anionic Watson-Crick(W–C)-like mismatches 
can increase the recruitment of replication and translation errors 
[53,54]. A sequence-dependent kinetic network system connects G•T/U 
wobbles with three particular W–C mismatches comprising of two 
quickly exchanging tautomeric species (Genol•T/U⇌G•Tenol/Uenol, 
population < 0.4%) and one anionic species (G•T− /U− , population 
≈0.001% at unbiased pH) [55]. 
3.7. Interpreting S gene mutations at the amino acid level 
The array of highly glycosylated spike (S) proteins present on the 
surface of SARS-CoV-2 bind to the host cell receptor called angiotensin- 
converting enzyme 2 (hACE2), and upon activation by a Type II trans-
membrane serine protease located on the host cell membrane, facilitate 
viral entry into the cell [56]. Owing to its crucial role in SARS-CoV-2 
infection the spike constitutes a key target for vaccine and drug devel-
opment against COVID-19 [57–59], and for the same reason it is 
imperative to interpret the mutations accumulating globally in the S 
gene at the amino acid level and evaluate their molecular biological 
significance. Furthermore, in this context, it is noteworthy that some/ 
many of the 2556 point mutations (1437 transitions with 428C➔U 
substitutions and 1119 transversions with 309 G➔U substitutions) 
detected across global S gene homologs (Tables 1 and 2) may put serious 
question marks on the eventual effectiveness of S-targeting vaccines/ 
drugs. 
2551 out of the 2556 instances of single nucleotide polymorphism 
detected were found to be distributed over the 12 different domains of 
the S protein; only 3 and 2 are in the upstream and splice regions 
respectively (Table 2). Of the 2551 mutations, again, 1615 are missense 
and 906 synonymous, while 30 generate stop codons within the reading 
frame (Table 2 and Fig. 3). Domain-wise, and across the 71,703 S protein 
homologs analyzed, mutation count per amino acid of the domain- 
length is maximum for the signal peptide (2.92) and lowest for the re-
ceptor binding domain (RBD, 1.68). 
Like most other SARS-CoV-2 genes, C➔U and G➔U were also found 
to be the most dominant transition and transversion types across global 
S gene homologs (Table 1). Out of the 428 C➔U transitions detected 
across S homologs, 234 (54.7%) constituted missense mutations, of 
which again 102 have resulted in the conversion of hydrophilic amino 
acids to hydrophobic ones (58 Thr➔Ile, 1 Thr➔Met, 25 Ser➔Phe, and 18 
Ser➔Leu; Supplementary File 2, Table S2). On the other hand, out of the 
309 G➔U transversions detected across global S gene homologs, 282 
(91.3%) constitute missense mutations, of which however only 41 have 
resulted in the conversion of hydrophilic amino acids to hydrophobic 
ones (16 Cys➔Phe, 12 Ser➔Ile, 6 Arg➔Ile, 5 Arg➔Leu, 2 Arg➔Met; 
Supplementary File 1, Table S1). Remarkably, in all the other genes of 
SARS-CoV-2, nonsynonymous amino acid replacements resulting from 
C➔U mutations have similar propensities for changing threonine and 
serine to isoleucine, leucine, methionine or phenylalanine (Supple-
mentary File 2, Table S2). Corroboratively, a significant positive corre-
lation (R = 0.99; P = 0.00001) was observed between the number of 
missense C➔U mutations in a gene and the number of hydrophilic to 
Table 2 
Structural domain-wise distribution of the major mutation-types detected across spike protein-encoding genes in 71,703 complete SARS-CoV-2 whole-genomes 
sequenced globally until 21 August 2020.  
Domains of SARS-CoV-2 
spike protein (span in 










No. of stops 
generated due 
to mutations 
No. of C➔U 
transitions 
(NCU) 
NCU resulting in 
non-synomymous 
mutations 






Upstream region 3a 0 0 0 1 0 0 0 
Signal peptide (1− 13) 38 24 14 0 6 4 4 4 
N-terminal Domain or NTD 
(14–305) 
696 468 221 7 101 58 85 77 
Peptide linking NTD with 
Receptor Binding 
Domain or RBD 
(306–318) 
31 21 10 0 5 2 1 1 
RBD (319–541) 375 208 157 10 61 24 33 29 
Peptide linking RBD with 
Fusion Peptide or FP 
(542–787) 
464 295 165 4 98 63 46 41 
FP (788–806) 37 26 11 0 4 3 2 2 
Peptide linking FP with 
Heptapeptide Repeat 
Sequence or HR1 
(807–911) 
227 140 85 2 41 23 28 25 
HR1 (912–984) 130 78 51 1 24 11 17 17 
Peptide linking HR1 with 
Heptapeptide Repeat 
Sequence or HR2 
(985–1162) 
315 192 118 5 51 32 46 41 
HR2 (1163–1213) 101 72 29 0 14 6 14 14 
Transmembrane domain 
(1213–1237) 
50 32 18 0 5 1 15 14 
Cytoplasmic domain 
(1237–1273) 
87 59 27 1 17 7 18 17 
Splice region 2b 0 0 0 0 0 0 0 
Total 2556 1615 906 30 428 234 309 282  
a These three mutations have non-coding effect. 
b One of these two mutations involved stop loss and the other a stop retention. 
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hydrophobic amino acid substitutions in the corresponding translated 
sequence. 
Hydrophobic interactions play critical roles in protein folding and 
structure determination, so replacement of amino acids by those having 
distinct hydrophobicities can contribute significantly to the evolution of 
proteins. Mutation trends presently revealed in global SARS-CoV-2 ge-
nomes corroborated a previous theory that most protein architectures 
are designed in such a way that in the early phases of evolution they 
have apparently unique functional specializations but in the course of 
evolution they can manipulate the effects of C➔U mutations in such a 
way as to expand the probability of hidden, optional plans being extri-
cated [60–62]. C➔U changes continually push amino acid contents of 
proteins towards more hydrophobic states, thereby unleashing the 
auxiliary plans of proteins on a fairly ordinary premise; in case suitable 
sections are present such optional plans can emerge as the new normals. 
C➔U mutations in the spike have also resulted in quite a few events 
of proline replacement (proline codons involve no guanosine, so 
expectedly none of the G➔U transversions affected any proline residue). 
Of the 234 global C➔U transitions yielding missense mutations in the 
spike, 50 have resulted in the substitution of proline residues (27 
Pro➔Ser, 23 Pro➔Leu; Supplementary File 2, Table S2). In all the other 
structural and non-structural genes as well, nonsynonymous amino acid 
substitution-yielding C➔U mutations exhibited global propensity for 
replacing proline to serine or leucine residues (Supplementary File 2, 
Table S2). Furthermore, a significant positive correlation (R = 0.97; P =
0.00001) was observed between the number of missense C➔U mutations 
accumulating in a gene and the number of proline replacements 
occurring in the corresponding translated sequence. In a protein 
sequence, when proline is replaced by serine or leucine a strong helix 
breaker is removed and replaced by a residue indifferent to helix for-
mation [63]. In the process conformational freedom of the protein is 
increased, which in the context of the spike can implicate versatile 
infectivity. 
The core of SARS-CoV-2 RBD consists of five antiparallel β sheets (β1, 
β2, β3, β4 and β7) connected by petite helices and loops. The receptor- 
binding motif (RBM), which mediates the contact with ACE2, lies be-
tween the β4 and β7 strands of the RBD core [64]. There are nine 
cysteine residues in RBD, of which eight are involved in the formation of 
Cys-Cys pairs: the three pairs Cys336-Cys361, Cys379-Cys432, and 
Cys391-Cys525 stabilize the β sheet structure, while the fourth one, 
Cys480-Cys488, bridges the loops present in the distal end of RBM [64]. 
The codons for Cys480, Cys488 and Cys525 are globally unaffected by 
any mutation; Cys361 and Cys391 involve instances of only synonymous 
mutations, while the remaining three cysteine residues have undergone 
substitution mutations, namely Cys336Arg, Cys379Phe and Cys432Phe 
(Supplementary File 1, Table S1). The fact that the cysteine pair Cys480- 
Cys488, through the entire evolutionary path of SARS-CoV-2, has 
remained unaffected by mutations reflects the indispensible (evolu-
tionarily chosen/selected) status of the relevant disulfide bonding in the 
spike protein’s structure and function. Corroborative to the apparent 
pivotal role of Cys480-Cys488 in spike architecture, this cysteine pair is 
also closest to the spike-hACE2 receptor interface as compared to the 
other cysteine pairs [65]. Likewise, from the trends of mutation 
revealed, structural indispensability was also apparent for Cys525 which 
has thus far remained unaffected by any mutation, and Cys391 where 
only one synonymous mutation has been selected across the 71,703 
homologs analyzed. The globally-conserved status of the Cys391-Cys525 
pair reinforces a previous hypothesis that this disulfide linkage which, in 
solution, is easily accessible to solvent molecules, could be a potent 
target for thiol group-containing therapeutic biochemicals towards 
structural dismantling of the spike protein [66]. Out of 39 amino acid 
residues of the spike that are reportedly responsible for binding with 
hACE2 [64,67], four residues (Phe486, Asn487, Cys488, and Gln498) 
are globally unaffected by any mutation; ten (Asp405, Tyr421, Leu455, 
Tyr473, Gln474, Tyr489, Leu492, Tyr495, Thr500, and Gly502) involve 
instances of only synonymous mutations, while the remaining 25 have 
undergone one or more instances of nonsynonymous substitutions 
(Supplementary File 2, Table S3). The likelihood of mutations being 
fixed in the genome depends on various factors, such as fitness of the 
phenotype or the position of the residues in the three-dimensional 
structure. Renewed studies of structural biology are required to reveal 
how these 25 substitutions individually alter the existing paradigm of 
RBD-hACE2 interaction. 
The unique amino acid residue Lys417, albeit lying outside the RBM, 
forms salt-bridge with the Asp30 residue of hACE2 [64]. In two separate 
instances of polymorphism across spike homologs, this Lys417 has been 
substituted by arginine (A➔G: Lys417Arg, a conservative replacement) 
and asparagine (G➔U: Lys417Asn, a radical replacement) (Supplemen-
tary File 2, Table S3). Lysine and arginine have similar size and charge, 
so their interchange may cause minimal secondary structure rear-
rangement [68]; but how such changes eventually influence the salt- 
bridge interaction with Asp30 of hACE2 is still unclear. Likewise, how 
the Lys417Asn substitution alters the spike-hACE2 interaction paradigm 
as a whole is also completely unknown. Whereas the jury is still out on 
the biophysical significances of the global array of missense mutations in 
the spike, they surely pose matters of concern for drug designers and 
vaccine developers worldwide. 
4. Conclusion 
The current investigation of 71,703 complete whole-genome se-
quences of SARS-CoV-2 isolates from across the world brought to the 
fore a number of remarkable aspects of microevolution of this novel 
coronavirus. Phylogenomic analysis illustrated that the two major- 
lineages of the virus have thus far contributed almost equivalently to 
the pandemic, even as members of the early lineages are still mostly 
spread over Asian countries and those of the relatively recent lineages 
have undergone more global distribution. In the coming days it would be 
worth exploring whether this viro-geography has any bearing on the 
differential death rates of COVID-19 in Asian and European/American 
countries (https://www.worldometers.info/coronavirus/). An over-
whelming preponderance of transition mutations, and far less frequency 
of transversions, was observed in the pan-genome of the virus, irre-
spective of whether the genetic locus encoded a non-structural or 
structural protein. In this context it is noteworthy that the 29,903 
nucleotide long SARS-CoV-2 pan-genome was found to have maintained 
a substantive 4965 transversion mutations, notwithstanding the fact 
that natural selection disfavors transversion mutations because they are 
often missense, so less likely to conserve the structural biological 
properties of the original amino acids. Likewise, positive selection of 
missense mutations (reflected in dN/dS values >1) in most of the 
structural genes of SARS-CoV-2 is indicative of vigorous molecular 
maneuvering by the virus to augment its virulence potentials, escape 
human immunity, and ensure enhanced global transmissibility. Among 
all transitions and transversion events in SARS-CoV-2, a molecular bias 
was observed for C➔U and G➔U substitutions respectively. Further-
more, in all the genes, nonsynonymous amino acid replacement-yeilding 
C➔U mutations were found to have a remarkable propensity for 
changing hydrophilic residues to hydrophobic ones. More comprehen-
sive and multi-faceted surveillance of the microevolution of SARS-CoV-2 
is needed to gain constant insights into the pathogenic dynamism of the 
virus, and improvise control and therapeutic strategies accordingly. 
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